Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MANIPALHOSNSE
MAXHEALTHNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
ARTEMISMEDNSE
Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 21% | 14% | 15% |
| - | 74% | 39% | 26% |
| - | 54% | 24% | 29% |
| 11% | 13% | 14% | 13% |
Peer Comparison
Symbol
APOLLOHOSP
MANIPALHOS
MAXHEALTH
ASTERDM
FORTIS
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
ARTEMISMED
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 7,872 | ₹112296 Cr | 53.74 | 40.39 | 207.67 | ₹1942 Cr |
| 642.4 | ₹85493 Cr | 95.81 | 1.96 | 11.95 | ₹892 Cr |
| 859.15 | ₹83023 Cr | 56.99 | 3.31 | 19.84 | ₹1442 Cr |
| 682.95 | ₹58873 Cr | 184.74 | 0.31 | 6.76 | ₹388 Cr |
| 743.95 | ₹56577 Cr | 53.99 | 3.53 | 20.1 | ₹1042 Cr |
| 1,726.4 | ₹34527 Cr | 42.31 | 10.14 | 65.36 | ₹806 Cr |
| 1,286.1 | ₹34407 Cr | 61.86 | 5.91 | 29.85 | ₹556 Cr |
| 1,887.4 | ₹32511 Cr | 59.99 | 10.11 | 42.51 | ₹505 Cr |
| 689.6 | ₹29188 Cr | 142.87 | 1.04 | 12.74 | ₹241 Cr |
| 472 | ₹14838 Cr | 100.01 | 1.43 | 13.88 | ₹133 Cr |
| 303.1 | ₹4777 Cr | 42.03 | 1.98 | 10.31 | ₹104 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Mar 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹287 Cr | ₹279 Cr | ₹272 Cr | ₹275 Cr | ₹255 Cr | ₹240 Cr | ₹232 Cr | ₹241 Cr | ₹223 Cr | ₹225 Cr | ₹219 Cr | ₹225 Cr | ₹210 Cr | ₹195 Cr | ₹187 Cr | ₹187 Cr | ₹167 Cr | ₹149 Cr | ₹144 Cr | ₹139 Cr | ₹122 Cr | ₹129 Cr | ₹124 Cr | ₹92 Cr | ₹63 Cr | ₹138 Cr | ₹144 Cr | ₹147 Cr | ₹140 Cr | ₹139 Cr |
| ₹5 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹12 Cr | ₹9 Cr | ₹7 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹86 L | ₹81 L | ₹1 Cr | ₹69 L | ₹88 L | ₹58 L | ₹2 Cr | ₹72 L | ₹1 Cr | ₹1 Cr | ₹63 L |
| ₹293 Cr | ₹287 Cr | ₹280 Cr | ₹282 Cr | ₹262 Cr | ₹252 Cr | ₹241 Cr | ₹249 Cr | ₹228 Cr | ₹227 Cr | ₹221 Cr | ₹227 Cr | ₹211 Cr | ₹198 Cr | ₹189 Cr | ₹189 Cr | ₹170 Cr | ₹151 Cr | ₹145 Cr | ₹140 Cr | ₹123 Cr | ₹131 Cr | ₹125 Cr | ₹93 Cr | ₹63 Cr | ₹141 Cr | ₹144 Cr | ₹149 Cr | ₹141 Cr | ₹140 Cr |
| ₹244 Cr | ₹240 Cr | ₹240 Cr | ₹236 Cr | ₹225 Cr | ₹216 Cr | ₹206 Cr | ₹210 Cr | ₹198 Cr | ₹198 Cr | ₹196 Cr | ₹201 Cr | ₹191 Cr | ₹178 Cr | ₹170 Cr | ₹171 Cr | ₹155 Cr | ₹139 Cr | ₹132 Cr | ₹125 Cr | ₹114 Cr | ₹114 Cr | ₹113 Cr | ₹90 Cr | ₹77 Cr | ₹131 Cr | ₹133 Cr | ₹136 Cr | ₹127 Cr | ₹127 Cr |
| ₹62 Cr | ₹59 Cr | ₹52 Cr | ₹58 Cr | ₹48 Cr | ₹48 Cr | ₹46 Cr | ₹50 Cr | ₹41 Cr | ₹40 Cr | ₹34 Cr | ₹37 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹25 Cr | ₹22 Cr | ₹18 Cr | ₹19 Cr | ₹21 Cr | ₹14 Cr | ₹22 Cr | ₹17 Cr | ₹9 Cr | -₹8 Cr | ₹15 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹18 Cr |
| ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| ₹43 Cr | ₹40 Cr | ₹30 Cr | ₹39 Cr | ₹30 Cr | ₹29 Cr | ₹27 Cr | ₹31 Cr | ₹22 Cr | ₹20 Cr | ₹16 Cr | ₹19 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹11 Cr | ₹8 Cr | ₹10 Cr | ₹13 Cr | ₹6 Cr | ₹17 Cr | ₹8 Cr | -₹35 L | -₹18 Cr | ₹6 Cr | ₹9 Cr | ₹9 Cr | ₹11 Cr | ₹10 Cr |
| ₹31 Cr | ₹30 Cr | ₹22 Cr | ₹30 Cr | ₹21 Cr | ₹23 Cr | ₹21 Cr | ₹22 Cr | ₹17 Cr | ₹14 Cr | ₹12 Cr | ₹14 Cr | ₹10 Cr | ₹11 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹13 Cr | ₹6 Cr | ₹8 Cr | ₹4 Cr | ₹13 Cr | ₹5 Cr | ₹3 L | -₹12 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — |
| ₹16 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹0 |
| ₹0 | ₹4 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹0 | ₹0 | ₹13 Cr |
| ₹919 Cr | ₹820 Cr | ₹428 Cr | ₹382 Cr | ₹338 Cr | ₹307 Cr | ₹300 Cr | ₹280 Cr |
| ₹850 Cr | ₹752 Cr | ₹360 Cr | ₹314 Cr | ₹272 Cr | ₹241 Cr | ₹234 Cr | ₹215 Cr |
| ₹69 Cr | ₹68 Cr | ₹68 Cr | ₹67 Cr | ₹67 Cr | ₹66 Cr | ₹66 Cr | ₹66 Cr |
| ₹935 Cr | ₹838 Cr | ₹448 Cr | ₹403 Cr | ₹359 Cr | ₹320 Cr | ₹313 Cr | ₹293 Cr |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹47 L | -₹7 L |
| ₹190 Cr | ₹209 Cr | ₹228 Cr | ₹214 Cr | ₹161 Cr | ₹108 Cr | ₹66 Cr | ₹53 Cr |
| ₹42 Cr | ₹36 Cr | ₹35 Cr | ₹30 Cr | ₹26 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr |
| ₹31 Cr | ₹40 Cr | ₹59 Cr | ₹39 Cr | ₹15 Cr | ₹16 Cr | ₹14 Cr | ₹0 |
| ₹65 Cr | ₹55 Cr | ₹41 Cr | ₹34 Cr | ₹24 Cr | ₹15 Cr | ₹6 Cr | ₹5 Cr |
| ₹327 Cr | ₹340 Cr | ₹363 Cr | ₹317 Cr | ₹226 Cr | ₹168 Cr | ₹115 Cr | ₹84 Cr |
| — | — | — | — | — | — | — | — |
| ₹98 Cr | ₹101 Cr | ₹95 Cr | ₹88 Cr | ₹60 Cr | ₹57 Cr | ₹75 Cr | ₹74 Cr |
| ₹93 Cr | ₹101 Cr | ₹78 Cr | ₹106 Cr | ₹68 Cr | ₹51 Cr | ₹63 Cr | ₹57 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹11 Cr | ₹38 Cr |
| ₹49 Cr | ₹14 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr |
| ₹240 Cr | ₹216 Cr | ₹185 Cr | ₹206 Cr | ₹138 Cr | ₹118 Cr | ₹158 Cr | ₹177 Cr |
| ₹1508 Cr | ₹1399 Cr | ₹1002 Cr | ₹930 Cr | ₹726 Cr | ₹609 Cr | ₹586 Cr | ₹554 Cr |
| ₹206 Cr | ₹145 Cr | ₹86 Cr | ₹65 Cr | ₹63 Cr | ₹35 Cr | ₹22 Cr | ₹8 Cr |
| ₹227 Cr | ₹246 Cr | ₹254 Cr | ₹242 Cr | ₹184 Cr | ₹127 Cr | ₹98 Cr | ₹114 Cr |
| — | — | — | — | — | — | — | — |
| ₹1037 Cr | ₹938 Cr | ₹885 Cr | ₹745 Cr | ₹598 Cr | ₹475 Cr | ₹466 Cr | ₹434 Cr |
| ₹233 Cr | ₹193 Cr | ₹166 Cr | ₹140 Cr | ₹109 Cr | ₹92 Cr | ₹73 Cr | ₹53 Cr |
| ₹804 Cr | ₹745 Cr | ₹719 Cr | ₹605 Cr | ₹489 Cr | ₹383 Cr | ₹393 Cr | ₹381 Cr |
| ₹28 Cr | ₹39 Cr | ₹33 Cr | ₹95 Cr | ₹62 Cr | ₹81 Cr | ₹56 Cr | ₹49 Cr |
| ₹216 Cr | ₹78 Cr | ₹68 Cr | ₹59 Cr | ₹45 Cr | ₹35 Cr | ₹19 Cr | ₹11 Cr |
| ₹63 Cr | ₹1 Cr | ₹71 L | ₹1 Cr | ₹57 L | ₹25 L | ₹59 L | ₹70 L |
| ₹1112 Cr | ₹864 Cr | ₹822 Cr | ₹760 Cr | ₹599 Cr | ₹499 Cr | ₹469 Cr | ₹442 Cr |
| — | — | — | — | — | — | — | — |
| ₹13 Cr | ₹10 Cr | ₹10 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹7 Cr |
| ₹120 Cr | ₹101 Cr | ₹95 Cr | ₹93 Cr | ₹73 Cr | ₹55 Cr | ₹77 Cr | ₹79 Cr |
| ₹206 Cr | ₹396 Cr | ₹61 Cr | ₹51 Cr | ₹28 Cr | ₹31 Cr | ₹16 Cr | ₹12 Cr |
| ₹14 Cr | ₹19 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr | ₹8 Cr | ₹9 Cr | ₹7 Cr |
| ₹42 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr |
| ₹396 Cr | ₹535 Cr | ₹180 Cr | ₹170 Cr | ₹127 Cr | ₹109 Cr | ₹118 Cr | ₹113 Cr |
| ₹156 Cr | ₹319 Cr | -₹5 Cr | -₹35 Cr | -₹11 Cr | -₹9 Cr | -₹40 Cr | -₹64 Cr |
| ₹1508 Cr | ₹1399 Cr | ₹1002 Cr | ₹930 Cr | ₹726 Cr | ₹609 Cr | ₹586 Cr | ₹554 Cr |
| ₹55 | ₹56 | ₹28 | ₹24 | ₹22 | ₹192 | ₹187 | ₹0 |
| ₹55 | ₹56 | ₹28 | ₹24 | ₹22 | ₹19 | ₹19 | ₹0 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| ₹139 Cr | ₹108 Cr | ₹68 Cr | ₹51 Cr | ₹37 Cr | ₹8 Cr | ₹31 Cr | ₹37 Cr |
| ₹50 Cr | ₹52 Cr | ₹60 Cr | ₹49 Cr | ₹38 Cr | ₹30 Cr | ₹34 Cr | ₹26 Cr |
| -₹40 Cr | ₹10 Cr | -₹4 Cr | ₹30 Cr | -₹33 Cr | -₹8 Cr | -₹5 Cr | -₹13 Cr |
| ₹149 Cr | ₹170 Cr | ₹124 Cr | ₹130 Cr | ₹43 Cr | ₹29 Cr | ₹60 Cr | ₹50 Cr |
| ₹132 Cr | ₹156 Cr | ₹109 Cr | ₹127 Cr | ₹60 Cr | ₹27 Cr | ₹56 Cr | ₹40 Cr |
| -₹90 Cr | -₹393 Cr | -₹88 Cr | -₹158 Cr | -₹107 Cr | -₹37 Cr | -₹26 Cr | -₹50 Cr |
| -₹50 Cr | ₹265 Cr | -₹29 Cr | ₹38 Cr | ₹44 Cr | ₹18 Cr | -₹27 Cr | ₹14 Cr |
| -₹8 Cr | ₹27 Cr | -₹8 Cr | ₹7 Cr | -₹3 Cr | ₹8 Cr | ₹2 Cr | ₹5 Cr |
| ₹42 Cr | ₹15 Cr | ₹23 Cr | ₹16 Cr | ₹19 Cr | ₹12 Cr | ₹9 Cr | ₹4 Cr |
| ₹33 Cr | ₹42 Cr | ₹15 Cr | ₹23 Cr | ₹16 Cr | ₹19 Cr | ₹12 Cr | ₹9 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 oscillators
RSI
36.98Sell
STOCH %K
3.93Buy
MACD Level(12,26)
-6.56Sell
Ultimate Oscillator
37.23Sell
Aroon Oscillator
74.00Buy
BOP
0.05Buy
CCI
-117.38Buy
Williams %R
-96.07Buy
Momentum
-29.60Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
313.96Sell
SMA 9
312.23Sell
EMA 21
323.22Sell
SMA 21
330.06Sell
EMA 50
319.84Sell
SMA 50
326.85Sell
EMA 200
284.83Buy
SMA 200
271.25Buy
WMA 20
322.84Sell
Pivot
Pivot
Classic
Resistance 5
357.35
Resistance 4
344.25
Resistance 3
331.15
Resistance 2
318.05
Resistance 1
309.90
Pivot
304.95
Support 1
296.80
Support 2
291.85
Support 3
278.75
Support 4
265.65
Support 5
252.55
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 58.39% | 58.39% | 58.39% | 58.39% | 66.53% | 66.53% |
| 12.45% | 12.29% | 12.19% | 12.47% | 0.37% | 0.24% |
| 0.99% | 1.10% | 1.20% | 1.22% | 2.26% | 2.80% |
| 0.92% | 1.30% | 1.69% | 1.69% | 2.01% | 1.96% |
| 27.25% | 26.92% | 26.53% | 26.23% | 28.83% | 28.47% |
Bulk & block deals
Name
Microcurves Trading Private Limited
Microcurves Trading Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 25 Sep 2026 | Purchase | 36.73 Cr | ₹365.80 | 10.04 L | Bulk | 0.634252 | NSE |
| 25 Sep 2026 | Sell | 36.76 Cr | ₹366.15 | 10.04 L | Bulk | 0.634252 | NSE |
Insider trading & SAST
Client name
International Finance Corporation
International Finance Corporation
Constructive Finance Private Limited
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 Feb 2026 | Other | Acquisition | 11.98 | 11.98 | 0 | — | 1.90 Cr | 29 Dec 2025 | Conversion Of Compulsorily Convertible Debentures (ccds) | 1,89,62,247 | SAST | 29(1) | — |
| 18 Nov 2025 | Other | Acquisition | 11.99 | 11.99 | 0 | — | 1.90 Cr | 15 Nov 2025 | Conversion Of Compulsorily Convertible Debentures (ccds) | 1,89,62,247 | SAST | 29(2) | — |
| 31 May 2024 | Promoter | Others | — | — | 0 | — | 4.12 Cr | 16 May 2024 | Creation | 4,11,59,625 | SAST | Reg31 | — |
Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
Artemis Medicare Services Ltd (AMSL) is engaged in the healthcare business. The company is a Sister Concern Of Apollo Tyres Limited The Largest Automobile Tyre Company In India.AMSL owns and
Corporate Actions
Date
Type
Details
Company details
Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Artemis Medicare Services Share Price
303.10+1.35 (+0.45%)
+29.55% past 1 Year
News
Artemis Medicare reports strong Q1 EBITDA growth with margin expansion YoY
Equity
ARTEMISMED
Artemis Medicare Q1 shows healthy year-on-year revenue growth trajectory
Equity
ARTEMISMED
Artemis Medicare Q1 FY27 net profit rises sharply on strong performance
Equity
ARTEMISMED
Artemis Medicare signs long-term management pact for 300+ bed Raipur hospital
Equity
ARTEMISMED
Artemis Medicare Q4 FY26 Results: Net Profit Grows 27.16% YoY to Rs 29.50 Crores
Equity
ARTEMISMED
Artemis Medicare reports Profit after tax of 29.54 Crores, in the March 2026 quarter
Equity
ARTEMISMED
Artemis Medicare Services Aims for Over 2,000 Beds Expansion with High Clinical Standards.
Equity
ARTEMISMED
Artemis Medicare Services Enters Agreement to Operate 650+ Bed Vimhans Hospital in South Delhi.
Equity
ARTEMISMED
Artemis Medicare Services gets nod to raise Rs 700 crore
Equity
ARTEMISMED
Artemis Medicare - Quaterly Results
Equity
ARTEMISMED
Artemis Medicare reports Profit after tax of 22.51 Crores, in the December 2025 quarter
Equity
ARTEMISMED
Artemis Medicare Services Q3 EBITDA Rises 19% YoY to Rs 44.60 Crores, Margin at 16.36%.
Equity
ARTEMISMED
Artemis Medicare Q3 FY26 Results: Revenue Growth 17.4% YoY, Net Profit Expansion
Equity
ARTEMISMED
Artemis Hospitals launches major multi-year, multi-city expansion; new beds, specialty focus, NCR push
Equity
ARTEMISMED
Artemis Medicare Q2 Earnings Report: Strong YoY Profit and Revenue Growth, Margins Expand
Equity
ARTEMISMED
Artemis Medicare reports Profit after tax of 29.96 Crores, in the September 2025 quarter
Equity
ARTEMISMED
Artemis Medicare Services informs about analyst meet
Equity
ARTEMISMED
Artemis Medicare Services informs about allotment of equity shares
Equity
ARTEMISMED
Artemis Medicare Services informs about change in management
Equity
ARTEMISMED
Artemis Medicare: Plans Major Growth With Over 1,100 Beds By Fy26, Adding New 300-Bed Hospital In Raipur And 550-Bed Hospital In South Delhi, Expanding To Tier-2 Cities And Abroad, Reports Strong Q1 Fy26 Results With Rs 83,900 Arpob And 28% Pat Growth. ??
Equity
ARTEMISMED

